VeroScience
VeroScience Presents Data on Newly FDA Approved Drug Cycloset at American Diabetes Association Annual Scientific Sessions
Published in Medical Letter on the CDC and FDA, June 28th, 2009
VeroScience, in collaboration with S2 Therapeutics, announced the presentation of clinical and preclinical data at the American Diabetes Association (ADA) 69th Scientific Sessions on Cycloset, a novel treatment for patients with Type 2 diabetes. FDA-approved in May 2009, Cycloset is the first therapy directly targeting the body's dopamine activity to improve glycemic control. It is also the only drug to be approved subsequent to the FDA's new guidelines that require studies demonstrating that diabetes drugs do not increase cardiovascular risk.
The data presented today reviewed the impact of adding Cycloset to the treatment regimen of patients with Type 2 diabetes who...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diabetes
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 - Immunization
Study Shows Pentacel® Combination Vaccine Provides Safety and Antibody Responses Comparable to Individually Administered US-licensed Vaccines - Life Sciences
Findings from Food & Drug Administration provide new insights into life sciences - Life Sciences
Reports by P.M. Hyman and co-researchers describe recent advances in life sciences - Life Sciences
Studies from Umea University add new findings in the area of life sciences - Pharmaceuticals
Data on pharmaceuticals described by researchers at University of Arkansas - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
